NIDCD
Stories
-
Cognixion enrolls participants in NIH-funded BCI study for ALS
Cognixion Corporation announced it is now enrolling 30 adults with ALS in the CHOICE study, a 12-week trial comparing its investigational brain-computer interface with eye-tracking devices. The study is supported by the National Institute on Deafness and Other Communication Disorders and is registered on ClinicalTrials.gov as NCT07871071.